Trial intelligence / Profile preview

Cesamet for Chemotherapy-induced Nausea and Vomiting

NCT00418678Phase 4Terminated

Sponsor
Veeda Lifesciences
Start
Aug 2006
Primary completion
Dec 2007
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of nabilone in chemotherapy-induced nausea and vomiting (CINV), sponsored by Veeda Lifesciences. Started Aug 2006; status: terminated.

02

Drugs

nabilone
03

Conditions

chemotherapy-induced nausea and vomiting (CINV)

Beyond the preview

Go deeper on NCT00418678.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00418678.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call